CHD5 and breast carcinoma: In this manuscript, we found that promoter methylation, genomic deletion and down-regulation of CHD5 at both RNA and protein levels are common in breast cancer, and CHD5 down-regulation was significantly associated with metastasis and worse patient survival in breast cancer.